Matthew E Ros insider trades

Open-market stock purchases and sales by Matthew E Ros, Chief Operating Officer at Jasper Therapeutics, Inc, from SEC Form 4 filings since Mar 22, 2010.

Recent trades

DateStockTradeValue
Jul 20, 2026JSPR Jasper Therapeutics, IncBought—

Companies traded

  • JSPR Jasper Therapeutics, Inc: 1 buy, last Jul 20, 2026
  • ARIA Ariad Pharmaceuticals Inc: other filings, last Mar 22, 2010

Get free alerts when Matthew E Ros files a new trade →